Ziopharm Oncology to Report First Quarter 2020 Financial Results and Host a Conference Call and Webcast on May 7, 2020
April 27 2020 - 8:30AM
Ziopharm Oncology, Inc. (Nasdaq: ZIOP), today announced the Company
will host a conference call and webcast on Thursday, May 7, at 4:30
pm EDT to provide a corporate update and discuss financial results
for the first quarter ended March 31, 2020. The call can be
accessed by dialing 1-877-451-6152 (U.S. and Canada) or
1-201-389-0879 (international). The passcode for the conference
call is 13701877. To access the live webcast or the subsequent
archived recording, visit the “Investors” section of the Ziopharm
website at www.ziopharm.com. The webcast will be recorded and
available for replay on the Company’s website for two weeks.
About Ziopharm Oncology, Inc. Ziopharm Oncology
is an immuno-oncology company focused on developing end-to-end
cost-effective solutions using its non-viral Sleeping Beauty
platform for T-cell receptor (TCR) and chimeric antigen receptor
(CAR) T-cell therapies and immune-stimulating gene therapy with
Controlled interleukin 12 (IL-12). The Sleeping Beauty platform
genetically modifies T cells with DNA plasmids to express TCRs to
target neoantigens inside and outside hotspots for solid tumors and
CAR to target CD19 for blood cancers using the Company’s “Rapid
Personalized Manufacturing” to produce and release CAR-T as soon as
the day after gene transfer. The Sleeping Beauty platform is being
advanced in collaboration with the National Cancer Institute, The
University of Texas MD Anderson Cancer Center and Eden BioCell. The
Company is also developing its Controlled IL-12 platform, or
Ad-RTS-hIL-12 plus veledimex, as monotherapy and in combination
with immune checkpoint inhibitors to treat brain cancer, including
in collaboration with Regeneron Pharmaceuticals.Ziopharm Contact:
Chris Taylor VP, Investor Relations and Corporate Communications T:
617.502.1881 E: ctaylor@ziopharm.com
ZIOPHARM Oncology (NASDAQ:ZIOP)
Historical Stock Chart
From Mar 2024 to Apr 2024
ZIOPHARM Oncology (NASDAQ:ZIOP)
Historical Stock Chart
From Apr 2023 to Apr 2024